Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-13-008082
Filing Date
2013-06-26
Accepted
2013-06-26 16:46:59
Documents
1
Period of Report
2013-06-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT rdgdoc.html 4  
1 PRIMARY DOCUMENT rdgdoc.xml 4 15836
  Complete submission text file 0001437749-13-008082.txt   17320
Mailing Address PFZER INC 235 EAST 42ND STREET NEW YORK NY 10017
Business Address
CORR PETER B (Reporting) CIK: 0001176312 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34641 | Film No.: 13934892

Mailing Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560
Business Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560 919-456-7800
Furiex Pharmaceuticals, Inc. (Issuer) CIK: 0001484478 (see all company filings)

EIN.: 271197863 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations